Personalized Nutrition Report
: Analysis on the Market, Trends, and TechnologiesThe personalized nutrition market is transitioning into clinically integrated, data-first offerings with measurable commercial scale: the market was $17,600,000,000 in 2024 and carries a projected compound annual growth rate of 13.5% according to the trend report used for this analysis. Investment and product activity concentrate where multi-omic inputs and real-time biomarkers can be operationalized into recurring services; winners will combine authoritative clinical outcomes with scalable digital delivery and supply-chain execution.
The last time we updated this report was 21 days ago. If there’s something missing or off, your tips are welcome!
Topic Dominance Index of Personalized Nutrition
The Dominance Index for Personalized Nutrition merges timelines of published articles, newly founded companies, and global search data to provide a comprehensive perspective into the topic.
Key Activities and Applications
- Biometric data capture and longitudinal monitoring — Continuous glucose monitors, targeted blood panels and short-form metabolic tests create the actionable signals that feed adaptive recommendations; this activity underpins clinical outcome measurement and recurring subscription value.
- Multi-omic profiling for nutrient targeting — DNA, microbiome, and metabolome assays are used to stratify risk and recommend precise nutrient interventions, with companies packaging these inputs into supplement or meal-planning outputs.
- Automated personalized formulation and fulfilment — Robotic blending and 3D-printing approaches convert individual profiles into single-serve supplements or nutrient-matched meals, reducing time-to-delivery and improving adherence; this capability is increasingly central to product differentiation.
- Digital therapeutics and payer integration — Nutrition programs validated against clinical endpoints (e.g. glycemic control, lipid outcomes) are being packaged as reimbursable interventions and integrated with care pathways, shifting revenue models from pure D2C to B2B2C with payers and providers.
- Practitioner enablement platforms — SaaS tools for dietitians and clinical teams scale personalization by standardizing assessments, automating meal plans and tracking adherence, enabling higher caseloads without compromising individualization.
Emergent Trends and Core Insights
- Shift from static genomics toward dynamic phenotyping. Real-time and short-interval measures (CGMs, urine metabolomics) are gaining priority over one-time DNA reports because they capture current biological responsiveness and drive immediate behavior change.
- Food-as-medicine commercialization. Companies that can demonstrate measurable clinical benefit and integrate meal delivery or medically tailored foods with payer pathways command premium margins and lower churn Performance Kitchen.
- Platformization vs ingredient specialization. The market will bifurcate: a small set of Aggregator platforms that synthesize multi-source data and deliver care at scale, and a set of Ingredient specialists (genomics, advanced diagnostics, novel manufacturing) that supply irreplaceable inputs.
- Regulatory and evidence thresholds are rising. Claims tied to disease management trigger formal validation requirements; companies seeking enterprise or reimbursement adoption must invest in outcome studies and clinical pathways.
- Behavioral layers determine commercial survival. Algorithms without consistent engagement fail; integrated human coaching or clinical touchpoints materially raise adherence and long-term outcomes Stronger U.
Technologies and Methodologies
- AI and machine learning recommendation engines — central to fusing genetics, microbiome, wearable and questionnaire data into individualized plans; platforms train on longitudinal response data to refine dosing and food choices.
- Next-generation, low-cost biomarker assays — rapid urine metabolomics and targeted blood panels create high-fidelity phenotypes that improve prediction of nutrient response and guide formulation.
- Automated manufacturing (robotic blending and 3D printing) — on-demand production systems enable single-user packets, gummy stacks or meal components tailored to analytical outputs, reducing inventory loss and increasing personalization granularity Nourished.
- Digital therapeutics frameworks — validated software interventions that meet clinical evidence standards and integrate with reimbursement and clinical workflows; these require regulatory-grade data governance and trial designs.
- Wearable and IoT integration — CGMs and activity/HRV sensors create closed-loop signals that allow real-time plan adjustments and personalized metabolic training protocols nutrisense.io.
Personalized Nutrition Funding
A total of 479 Personalized Nutrition companies have received funding.
Overall, Personalized Nutrition companies have raised $8.3B.
Companies within the Personalized Nutrition domain have secured capital from 1.8K funding rounds.
The chart shows the funding trendline of Personalized Nutrition companies over the last 5 years
Personalized Nutrition Companies
- Melico Sciences Ltd. — A London-based diagnostics company that builds a metabolic fingerprint from a rapid urine test and translates thousands of metabolites into personalized dietary advice and measurable progress tracking. Their approach emphasizes short-interval feedback loops to show objective changes after dietary intervention, positioning them as a high-fidelity phenotyping supplier for platforms that need up-to-date metabolic inputs.
- PHRQL, Inc. — Developer of practice management and meal-planning SaaS for supermarket-embedded dietitians and health plans; their FoodScription™ product targets scale by enabling dietitians to manage large member cohorts with standardized, evidence-linked meal prescriptions. PHRQL's positioning makes it a likely B2B partner for payers attempting to operationalize food-as-medicine at population scale.
- NUSEUM — Seoul-based AI precision nutrition startup that trains on thousands of clinical studies; offers interactive AI assistants and has live PoCs with large commerce and bio partners. Their platform focus on enterprise integrations (commerce, insurance, delivery) makes them a regional aggregator candidate for APAC partners seeking to embed nutrition into consumer journeys.
- Panaceutics Nutrition, Inc. — Small US manufacturer that provides automated, small-batch blending and contract production for personalized supplements. Their manufacturing IP and ability to produce variable micro-batches at lower marginal cost position them as a critical supply partner for brands that need customized pills, powders or single-serve packs.
- 3X4 Genetics — Genomics-driven nutrition and performance firm focused on translating multi-gene panels into food, supplement and training recommendations for athletes and highly motivated consumers. Their depth in genetic interpretation and athlete use cases gives platforms a tested genomic module that integrates into broader personalization engines.
Delve into the corporate landscape of Personalized Nutrition with TrendFeedr’s Companies tool
5.0K Personalized Nutrition Companies
Discover Personalized Nutrition Companies, their Funding, Manpower, Revenues, Stages, and much more
Personalized Nutrition Investors
TrendFeedr’s Investors tool provides insights into 2.0K Personalized Nutrition investors for you to keep ahead of the curve. This resource is critical for analyzing investment activities, funding trends, and market potential within the Personalized Nutrition industry.
2.0K Personalized Nutrition Investors
Discover Personalized Nutrition Investors, Funding Rounds, Invested Amounts, and Funding Growth
Personalized Nutrition News
TrendFeedr’s News feature offers you access to 1.4K articles on Personalized Nutrition. Stay informed about the latest trends, technologies, and market shifts to enhance your strategic planning and decision-making.
1.4K Personalized Nutrition News Articles
Discover Latest Personalized Nutrition Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
Personalized nutrition has moved past proof-of-concept and now requires orchestration across diagnostics, algorithmic synthesis and product delivery to capture durable value. The most valuable assets will be high-quality longitudinal response datasets, validated outcome evidence, and the operational ability to convert recommendations into consumed, reimbursed products or services. Strategically, risk-averse incumbents should seek validated niche partners (phenotyping labs, automated formulators, or practitioner SaaS) while challengers should pursue focused clinical endpoints that enable payer engagement. Investment decisions should prioritize companies that demonstrate measurable clinical impact, scalable fulfillment, and privacy-first data stewardship.
Are you an insider in the trends or tech industry? We’d love for you to contribute to our content.
